Cite
HARVARD Citation
Mathieu, C. et al. (2013). Effectiveness and tolerability of second‐line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real‐life worldwide observational study (EDGE). International journal of clinical practice. 67 (10), pp. 947-956. [Online].